Atlas Pharmaceuticals, LLC is recalling 10,582 vials of injectable veterinary drugs, including Buprenorphine (a pain reliever) and Glycopyrrolate (used during anesthesia), due to a lack of assurance of sterility. Using a non-sterile injectable medication in animals can lead to serious infections at the injection site or systemic illness. This voluntary recall affects three distinct product strengths and sizes distributed nationwide. No incidents or injuries have been reported to date.
The lack of sterility assurance means these injectable medications may contain bacteria or other contaminants. This poses a risk of infection or other serious health complications for animals receiving the injections.
You have 2 options:
Quantity: 7,707 vials. Recall #: V-0138-2021.
Quantity: 2,714 vials. Recall #: V-0139-2021.
Quantity: 161 vials. Recall #: V-0140-2021.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response